BAMCO Inc
NEOS

BAMCO Inc’s Neos Therapeutics, Inc NEOS Stock Holding History

BAMCO Inc’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-70,500
Closed -$412K – 340
2016
Q4 		$412K Buy
70,500
+9,000
+15% +$60.9K ﹤0.01% 304
2016
Q3 		$405K Buy
61,500
+33,500
+120% +$265K ﹤0.01% 292
2016
Q2 		$260K Buy
28,000
+13,000
+87% +$124K ﹤0.01% 288
2016
Q1 		$162K Buy
15,000
+5,000
+50% +$52.7K ﹤0.01% 285
2015
Q4 		$143K Sell
10,000
-31,600
-76% -$477K ﹤0.01% 308
2015
Q3 		$874K Buy
+41,600
New +$917K ﹤0.01% 313

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

BAMCO Inc's NEOS Position: Q1 2017 in Review

BAMCO Inc sold out of Neos Therapeutics, Inc (NEOS) in Q1 2017, closing a stake of 70,500 shares — an estimated $412K sold.

BAMCO Inc first reported a position in NEOS in Q3 2015 and held it in 6 quarters. The position peaked at $874K in Q3 2015. 49 funds tracked by Wall St. Rank hold NEOS as of Q1 2017.

  • BAMCO Inc reported no remaining Neos Therapeutics, Inc position as of Q1 2017 after selling out during the quarter.
  • BAMCO Inc sold 70,500 Neos Therapeutics, Inc shares in Q1 2017, an estimated $412K.
  • BAMCO Inc first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 6 quarters.
  • BAMCO Inc's Neos Therapeutics, Inc position peaked at $874K in Q3 2015.
  • 49 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2017.

Based on BAMCO Inc's 13F filing for Q1 2017, filed 15 May 2017.